Manya Angley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Manya Angley has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Deirdre Criddle
Complex Needs Coordination Team and Sir Charles Gairdner Hospital Pharmacy Department, Sir Charles Gairdner, Nedlands, Australia
4 shared publications - Jonathan Penm
Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, Australia
4 shared publications - Rohan A. Elliott
Pharmacy Department Austin Health Heidelberg Victoria Australia
4 shared publications - Anna Packer
Western NSW Local Health District, Dubbo, Australia
2 shared publications - Charley Budgeon
School of Population and Global Health, University of Western Australia, Perth, Australia
2 shared publications - Cristen Fleming
Western NSW Local Health District, Dubbo, Australia
2 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 48 (6) , 2504-2512
Proportion of patients admitted to rural and remote hospitals that experience a 30-day medication-related readmission: a retrospective cohort study
Introduction: Medication-related readmissions are a significant and preventable cause of patient harm. Patients living in rural and remote areas may face inequitable access to healthcare and fragmented continuity of care, increasing their vulnerability to medication-related harm. Despite this, the burden and drivers of medication-related readmissions in these settings remain poorly understood. Determining the current burden and identifying factors associated with medication-related readmissions is essential to inform targeted strategies to improve medication safety. Aim: To determine the proportion of adult patients with a medication-related readmission within 30 days of discharge from rural and remote hospitals, and to identify factors potentially associated with these readmissions. Method: A retrospective cohort study was conducted using medical records of adults admitted to rural and remote hospitals in New South Wales, Australia, between June 1, 2022 and August 31, 2023. Readmissions within 30 days were assessed for medication-related causes using the AT-HARM10, a validated 10-item tool based on admission notes, medication lists, inpatient pathology results, and discharge summaries. Patient demographics, comorbidities and admission details were extracted. Comorbidity burden was calculated using the Charlson Comorbidity Index (CCI). Medication lists were based on medications charted 12 h before discharge. Univariable logistic regression was performed to explore factors associated with 30-day medication-related readmissions, with results reported as unadjusted odds ratios (uOR). Results: Of the 2220 patients admitted during the study period, 6% (n = 133) experienced a 30-day readmission, of which 22.5% (n = 30) were medication-related. Overall, 1.4% of all admitted patients experienced a 30-day medication-related readmission. Older age (uOR 1.04; 95% CI 1.01–1.07), higher CCI (uOR 1.22; 95% CI 1.04–1.44), a greater number of regular medications (uOR 1.07 per additional medication; 95% CI 1.01–1.14), and insulin use (uOR 2.80; 95% CI 1.06–7.42) were associated with medication-related readmission. Conclusion: In rural and remote hospitals, a small but clinically important proportion of patients experienced a medication-related readmission within 30 days of discharge. Unadjusted analysis identified that older age, multimorbidity, polypharmacy and insulin use were associated with increased risk. Larger studies are needed to validate these findings and evaluate strategies to reduce medication-related harm in rural and remote populations.
- 7 October 2026
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 48 (6) , 2504-2512
Open AccessProportion of patients admitted to rural and remote hospitals that experience a 30-day medication-related readmission: a retrospective cohort study
Introduction: Medication-related readmissions are a significant and preventable cause of patient harm. Patients living in rural and remote areas may face inequitable access to healthcare and fragmented continuity of care, increasing their vulnerability to medication-related harm. Despite this, the burden and drivers of medication-related readmissions in these settings remain poorly understood. Determining the current burden and identifying factors associated with medication-related readmissions is essential to inform targeted strategies to improve medication safety. Aim: To determine the proportion of adult patients with a medication-related readmission within 30 days of discharge from rural and remote hospitals, and to identify factors potentially associated with these readmissions. Method: A retrospective cohort study was conducted using medical records of adults admitted to rural and remote hospitals in New South Wales, Australia, between June 1, 2022 and August 31, 2023. Readmissions within 30 days were assessed for medication-related causes using the AT-HARM10, a validated 10-item tool based on admission notes, medication lists, inpatient pathology results, and discharge summaries. Patient demographics, comorbidities and admission details were extracted. Comorbidity burden was calculated using the Charlson Comorbidity Index (CCI). Medication lists were based on medications charted 12 h before discharge. Univariable logistic regression was performed to explore factors associated with 30-day medication-related readmissions, with results reported as unadjusted odds ratios (uOR). Results: Of the 2220 patients admitted during the study period, 6% (n = 133) experienced a 30-day readmission, of which 22.5% (n = 30) were medication-related. Overall, 1.4% of all admitted patients experienced a 30-day medication-related readmission. Older age (uOR 1.04; 95% CI 1.01–1.07), higher CCI (uOR 1.22; 95% CI 1.04–1.44), a greater number of regular medications (uOR 1.07 per additional medication; 95% CI 1.01–1.14), and insulin use (uOR 2.80; 95% CI 1.06–7.42) were associated with medication-related readmission. Conclusion: In rural and remote hospitals, a small but clinically important proportion of patients experienced a medication-related readmission within 30 days of discharge. Unadjusted analysis identified that older age, multimorbidity, polypharmacy and insulin use were associated with increased risk. Larger studies are needed to validate these findings and evaluate strategies to reduce medication-related harm in rural and remote populations.
- Open Access
- 17 May 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (5) , e70586
Medication Management Strategies at Hospital Admission: A Systematic Review and Meta‐Analysis
Hospital admission is high risk for medication harm due to transfer errors, delays, and charting mistakes. Up to 70% of admission medication lists contain errors, 59% potentially harmful, highlighting the need for safety strategies. The aim of the study is to systematically review the effectiveness of strategies for medication management at hospital admission. Following PRISMA guideline, three databases were searched for RCTs. Subgroup analyses assessed outcomes including mortality, readmissions/Emergency Department (ED) visits, length of stay (LOS), medication errors, and adverse drug events (ADEs), with meta‐analysis where possible. Nineteen RCTs were included. The strategies were classified into five categories: medication reconciliation, supported medication review, collaborative model of medication review, Partnered Pharmacist Medication Charting (PPMC), and real‐time health information exchange (HIE) tools. Medication reconciliation alone showed limited effectiveness in reducing medication errors and ADEs while combining with other strategies was more effective in minimizing ADEs. The meta‐analysis showed that PPMC can be considered a potential strategy to reduce medication errors and ADEs. Outcomes such as readmission, ED visits, mortality, and LOS were reported as secondary outcomes, and the strategies showed no significant effect in improving them. Overall admission strategies can reduce medication‐related outcomes such as medication errors and ADEs; however, stronger evidence is needed to confirm their impact on other outcomes. Future research should focus on integrating Clinical Decision Support (CDS) and stratification tools into electronic medical records to enhance the efficiency of these tools.
- 17 May 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (5) , e70586
Open AccessMedication Management Strategies at Hospital Admission: A Systematic Review and Meta‐Analysis
Hospital admission is high risk for medication harm due to transfer errors, delays, and charting mistakes. Up to 70% of admission medication lists contain errors, 59% potentially harmful, highlighting the need for safety strategies. The aim of the study is to systematically review the effectiveness of strategies for medication management at hospital admission. Following PRISMA guideline, three databases were searched for RCTs. Subgroup analyses assessed outcomes including mortality, readmissions/Emergency Department (ED) visits, length of stay (LOS), medication errors, and adverse drug events (ADEs), with meta‐analysis where possible. Nineteen RCTs were included. The strategies were classified into five categories: medication reconciliation, supported medication review, collaborative model of medication review, Partnered Pharmacist Medication Charting (PPMC), and real‐time health information exchange (HIE) tools. Medication reconciliation alone showed limited effectiveness in reducing medication errors and ADEs while combining with other strategies was more effective in minimizing ADEs. The meta‐analysis showed that PPMC can be considered a potential strategy to reduce medication errors and ADEs. Outcomes such as readmission, ED visits, mortality, and LOS were reported as secondary outcomes, and the strategies showed no significant effect in improving them. Overall admission strategies can reduce medication‐related outcomes such as medication errors and ADEs; however, stronger evidence is needed to confirm their impact on other outcomes. Future research should focus on integrating Clinical Decision Support (CDS) and stratification tools into electronic medical records to enhance the efficiency of these tools.
- Open Access
- 20 August 2024
- Published by Therapeutic Guidelines Limited in Australian Prescriber
- Vol. 47 (4) , 106-108
Editorial: Achieving safe medication management during transitions of care from hospital: time for a stewardship approach
An interdisciplinary stewardship approach is proposed to address the intractable problem of medication errors and harms following hospital discharge.
- 20 August 2024
- Published by Therapeutic Guidelines Limited in Australian Prescriber
- Vol. 47 (4) , 106-108
Open AccessEditorial: Achieving safe medication management during transitions of care from hospital: time for a stewardship approach
An interdisciplinary stewardship approach is proposed to address the intractable problem of medication errors and harms following hospital discharge.
- 6 October 2022
- Published by Wiley in Journal of Pharmacy Practice and Research
- Vol. 52 (6) , 446-453
Hospital‐initiated post‐discharge medication reviews in Australia: expert opinion on the barriers and enablers to implementation
Medication‐related harm can occur during transitions of care. Revised Home Medicines Review (HMR) and Residential Medication Management Review (RMMR) program rules were published in April 2020 which allowed provision for some hospital medical practitioners to refer at‐risk patients for medication review. In turn, the Society of Hospital Pharmacists of Australia's (SHPA's) Transitions of Care and Primary Care Leadership Committee developed a framework to support hospitals facilitating Hospital‐Initiated Medication Reviews (HIMRs) via three pathways: HMR, RMMR, and Hospital Outreach Medication Review. Following the compilation of draft barriers and enablers to implementation of the SHPA HIMR framework, refinement occurred after broad consultation with hospital‐ and primary care‐based pharmacists with transitions of care experience. The finalised list of barriers and enablers can inform broadscale implementation of the SHPA HIMR framework to reduce medication‐related harm when high‐risk patients transition from hospital to primary care and aged care.
- 6 October 2022
- Published by Wiley in Journal of Pharmacy Practice and Research
- Vol. 52 (6) , 446-453
Hospital‐initiated post‐discharge medication reviews in Australia: expert opinion on the barriers and enablers to implementation
Medication‐related harm can occur during transitions of care. Revised Home Medicines Review (HMR) and Residential Medication Management Review (RMMR) program rules were published in April 2020 which allowed provision for some hospital medical practitioners to refer at‐risk patients for medication review. In turn, the Society of Hospital Pharmacists of Australia's (SHPA's) Transitions of Care and Primary Care Leadership Committee developed a framework to support hospitals facilitating Hospital‐Initiated Medication Reviews (HIMRs) via three pathways: HMR, RMMR, and Hospital Outreach Medication Review. Following the compilation of draft barriers and enablers to implementation of the SHPA HIMR framework, refinement occurred after broad consultation with hospital‐ and primary care‐based pharmacists with transitions of care experience. The finalised list of barriers and enablers can inform broadscale implementation of the SHPA HIMR framework to reduce medication‐related harm when high‐risk patients transition from hospital to primary care and aged care.
- Open Access
- 1 June 2020
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 15, 797-809
Simplifying Medication Regimens for People Receiving Community-Based Home Care Services: Outcomes of a Non-Randomized Pilot and Feasibility Study
Purpose: Being able to manage a complex medication regimen is key to older people continuing to live at home. This study determined the feasibility of a multi-component intervention to simplify medication regimens for people receiving community-based home care services. Patients and Methods: Research nurses recruited people receiving community-based home care services to participate in this non-randomized pilot and feasibility study (Australian New Zealand Clinical Trials Registry ACTRN12618001130257). Participants received a one-off clinical pharmacist intervention comprising medication reconciliation, assessment of capacity to self-manage medications, and application of a structured 5-step tool to identify medication simplification opportunities. A mixed-methods feasibility assessment with an explanatory design was undertaken to assess recruitment, protocol adherence and stakeholder acceptability. Data from interviews with 12 stakeholders were thematically analyzed. Secondary outcome measures, including medication discrepancies, and changes in number of medication administration times per day, quality of life, medication adherence and health service utilization, were determined over a 4-month follow-up. Results: Twenty-five out of the target 50 participants were recruited. Initial recruitment was impacted by apparent uncertain role responsibilities in medication management, with some clients who declined to participate perceiving they would be unlikely to benefit or being reluctant to change regimens. However, with few exceptions, participants who received intervention did so with a high degree of protocol adherence and acceptability. Stakeholders valued the intervention and supported wider implementation. Discrepancies between the baseline medication history from the general medical practitioner and the pharmacist-compiled “best possible medication history” were identified for all participants’ regimens (median of 6 per participant), with one-third resolved at follow-up. Simplification was possible for 14 participants (56%) and implemented for 7 (50%) at follow-up. No significant changes in other secondary outcomes were observed. Conclusion: The intervention was delivered as planned, and valued by stakeholders. Recruitment barriers should be addressed before wider implementation.
- 1 June 2020
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 15, 797-809
Open AccessSimplifying Medication Regimens for People Receiving Community-Based Home Care Services: Outcomes of a Non-Randomized Pilot and Feasibility Study
Purpose: Being able to manage a complex medication regimen is key to older people continuing to live at home. This study determined the feasibility of a multi-component intervention to simplify medication regimens for people receiving community-based home care services. Patients and Methods: Research nurses recruited people receiving community-based home care services to participate in this non-randomized pilot and feasibility study (Australian New Zealand Clinical Trials Registry ACTRN12618001130257). Participants received a one-off clinical pharmacist intervention comprising medication reconciliation, assessment of capacity to self-manage medications, and application of a structured 5-step tool to identify medication simplification opportunities. A mixed-methods feasibility assessment with an explanatory design was undertaken to assess recruitment, protocol adherence and stakeholder acceptability. Data from interviews with 12 stakeholders were thematically analyzed. Secondary outcome measures, including medication discrepancies, and changes in number of medication administration times per day, quality of life, medication adherence and health service utilization, were determined over a 4-month follow-up. Results: Twenty-five out of the target 50 participants were recruited. Initial recruitment was impacted by apparent uncertain role responsibilities in medication management, with some clients who declined to participate perceiving they would be unlikely to benefit or being reluctant to change regimens. However, with few exceptions, participants who received intervention did so with a high degree of protocol adherence and acceptability. Stakeholders valued the intervention and supported wider implementation. Discrepancies between the baseline medication history from the general medical practitioner and the pharmacist-compiled “best possible medication history” were identified for all participants’ regimens (median of 6 per participant), with one-third resolved at follow-up. Simplification was possible for 14 participants (56%) and implemented for 7 (50%) at follow-up. No significant changes in other secondary outcomes were observed. Conclusion: The intervention was delivered as planned, and valued by stakeholders. Recruitment barriers should be addressed before wider implementation.